Veradermics, Incorporated

Healthcare

NYSE:MANE · New York Stock Exchange

Market Cap $3.92B Beta 0.58 P/E (TTM) -61.9

$93.87 -1.23%

-$1.13 today

52W Low $32.00High $117.71

Vol 0.82M · Avg 0.58M

EPS (TTM) -$1.47Biotechnology

Filings

Ground the analysis in primary documents

Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.

Price History

Dividend-adjusted closing price

Events

Change

+148.66%

Period High

$114.80

Period Low

$37.03

Latest

$93.87

SEC Filings

Recent regulatory filings

No filings found.

Competitors

Peer companies in the same sector

Health

Travere Therapeutics, Inc.

NASDAQ:TVTX

$5.05B

Abeona Therapeutics Inc.

NASDAQ:ABEO

$324.30M

Ovid Therapeutics Inc.

NASDAQ:OVID

$309.27M

Cybin Inc. Common Stock

NASDAQ:HELP

$225.02M

Tharimmune, Inc.

THAR

$139.94M

Polaryx Therapeutics, Inc. Common Stock

NASDAQ:PLYX

$110.57M

Lisata Therapeutics, Inc.

LSTA

$32.56M

XTL Biopharmaceuticals Ltd.

XTLB

$5.69M

Adial Pharmaceuticals, Inc.

ADIL

$2.68M

Dermata Therapeutics, Inc.

DRMA

$863,260.00

Explore More

Continue the stock analysis

Jump to another research area for this company.

OverviewStart with valuation, alerts, peers, and the full company snapshot.DCFAdjust assumptions and compare intrinsic value against the market price.FinancialsReview income statement, balance sheet, and cash flow trends.HealthCheck liquidity, leverage, and balance sheet strength.GrowthCompare historical growth, cash generation, targets, and peers.DividendsInspect dividend history, payout durability, and shareholder returns.ManagementReview leadership context, insider activity, and capital efficiency.